Literature DB >> 30343505

Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia.

Kent A Willis1, Mark F Weems1.   

Abstract

Patent ductus arteriosus (PDA) is prevalent in premature newborns and has been linked to the development of bronchopulmonary dysplasia (BPD), a serious pulmonary complication of premature birth. Although a causal relationship has not been proven, the link is greatest among infants born at lower gestational age who are treated with mechanical ventilation in the presence of a large ductal shunt. Despite strong association in epidemiological studies, treatment of a patent ductus arteriosus has not been shown to prevent BPD, and some therapies may increase the risk of BPD. We describe preclinical and clinical data demonstrating the association of a PDA with BPD, highlight the effects of surgical and pharmacological treatment, and explore the implications of recent clinical trials for the management of PDA in the premature newborn.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  bronchopulmonary dysplasia; neonatal; patent ductus arteriosus

Mesh:

Year:  2018        PMID: 30343505     DOI: 10.1111/chd.12691

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  5 in total

1.  Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China.

Authors:  Tongyan Han; Huiqiang Liu; Hui Zhang; Ming Guo; Xuefeng Zhang; Yang Duan; Fuqiang Sun; Xinjian Liu; Xiang Zhang; Mingtao Zhang; Fang Liu; Lisha Bao; Min Xiao; Weili Liu; Rui Jiang; Jun Zheng; Xiuying Tian; Qi Gao; Wanxian Zhang; Wei Guo; Ling Li; Xiaomei Tong
Journal:  Front Pediatr       Date:  2020-05-07       Impact factor: 3.418

2.  Morbidity associated with patent ductus arteriosus in preterm newborns: a retrospective case-control study.

Authors:  Gianluca Terrin; Maria Di Chiara; Giovanni Boscarino; Valentina Metrangolo; Francesca Faccioli; Elisa Onestà; Antonella Giancotti; Violante Di Donato; Viviana Cardilli; Mario De Curtis
Journal:  Ital J Pediatr       Date:  2021-01-14       Impact factor: 2.638

Review 3.  Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?

Authors:  Rishika P Sakaria; Ramasubbareddy Dhanireddy
Journal:  Front Pediatr       Date:  2022-03-09       Impact factor: 3.418

4.  Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.

Authors:  Solomiia Potsiurko; Dmytro Dobryanskyy; Lesya Sekretar
Journal:  BMC Pediatr       Date:  2021-06-19       Impact factor: 2.125

5.  Effect of Nonintervention vs Oral Ibuprofen in Patent Ductus Arteriosus in Preterm Infants: A Randomized Clinical Trial.

Authors:  Se In Sung; Myung Hee Lee; So Yoon Ahn; Yun Sil Chang; Won Soon Park
Journal:  JAMA Pediatr       Date:  2020-08-01       Impact factor: 16.193

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.